Rosuvastatin induces renal HO-1 activity and expression levels as a main protective mechanism against STZ-induced diabetic nephropathy

GH Heeba, MAM Ali, AAK El-Sheikh - Medicina, 2022 - mdpi.com
Background and Objectives: Nephroprotective effect of statins is still controversial. The aim
of this study was to investigate the possible hemin-like nephroprotective effect of …

Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats

MMA Hussein, MK Mahfouz - Biomedicine & Pharmacotherapy, 2016 - Elsevier
The development of diabetic nephropathy (DN) relays mainly on control of blood glucose
and restrains hyperglycemic-induced oxidative stress. Hence, the effect administration of …

[HTML][HTML] Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model

S Zhang, H Xu, X Yu, Y Wang, F Sun… - International Journal of …, 2015 - ncbi.nlm.nih.gov
The present study aims to study the possible renal protective effect of simvastatin in the
development and progression of type 2 diabetic nephropathy. A rat model of T2DN was …

Role of oxidative stress and reduced endogenous hydrogen sulfide in diabetic nephropathy

A Hussain Lodhi, FD Ahmad, K Furwa… - Drug Design …, 2021 - Taylor & Francis
Purpose Persistent hyperglycemia lead towards depletion of hydrogen sulfide (H2S)
resulting in generation of oxidative stress and diabetic nephropathy. The aim of the current …

Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling

CW Kuo, CJ Shen, YT Tung, HL Chen, YH Chen… - Life sciences, 2015 - Elsevier
Aim Diabetic nephropathy is the leading cause of end stage renal disease in developed
countries throughout the world. The imbalance between the production of reactive oxygen …

Valsartan reduces NOX4 expression and halts diabetic nephropathy in streptozotocin induced diabetic rat model

SA Maher, LA Tag Eldeen, DI Badran… - Bulletin of the National …, 2019 - Springer
Background Diabetic nephropathy is the leading cause of kidney failure worldwide. NADPH
oxidase 4 (NOX4) is an obvious cause for reactive oxygen species production in the kidney …

Renoprotective effect of atorvastatin on STZ-diabetic rats through attenuating kidney-associated dysmetabolism

S Zhou, P Zhao, Y Li, T Deng, L Tian, H Li - European Journal of …, 2014 - Elsevier
Atorvastatin (AT) has been alternatively used for managing diabetic complications in clinic.
However, AT-related therapeutic potentiality remains relatively unexplored, especially in …

[HTML][HTML] Simvastatin ameliorates diabetic nephropathy by attenuating oxidative stress and apoptosis in a rat model of streptozotocin-induced type 1 diabetes

NM Al-Rasheed, NM Al-Rasheed, YA Bassiouni… - Biomedicine & …, 2018 - Elsevier
Statins are HMG-CoA reductase inhibitors with lipid-lowering effect and commonly used to
reduce cardiovascular risk in diabetic patients. The present study investigates the …

[PDF][PDF] Renoprotective effect of atorvastatin on STZ-diabetic rats through inhibiting inflammatory factors expression in diabetic rat.

D Liao, YQ Liu, LY Xiong… - European Review for …, 2016 - europeanreview.org
OBJECTIVE: Though increasing evidences showed that statins had potential benefits to
diabetic kidney disease (DKD), its mechanism has not been completely elucidated yet. The …

Pitavastatin Upregulates Nitric Oxide Synthases in the Kidney of Spontaneously Hypertensive Rats and Wistar–Kyoto Rats

G Hu, O Ito, R Rong, A Sakuyama… - American journal of …, 2018 - academic.oup.com
BACKGROUND Clinical trials show potent renoprotective effects of pitavastatin (PTV),
although the precise mechanism for these renoprotective effects is not fully clarified. The aim …